A2B5-REACTIVE GANGLIOSIDE EXPRESSION DETERMINES THE DIFFERENTIATION STAGE AND CAPACITY OF RAT INSULINOMA (RIN) SUBLINES

被引:6
作者
BARTHOLOMEUSZ, RK [1 ]
CAMPBELL, IL [1 ]
HARRISON, LC [1 ]
机构
[1] ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,BURNET CLIN RES UNIT,PARKVILLE,VIC 3050,AUSTRALIA
来源
CELL DIFFERENTIATION AND DEVELOPMENT | 1990年 / 32卷 / 01期
基金
英国医学研究理事会;
关键词
A2B5-reactive; A2B5-reactive ganglioside; Differentiation; Ganglioside expression; Insulinoma subline; Rat;
D O I
10.1016/0922-3371(90)90097-G
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have generated rat insulinoma (RIN) sublines AlGh, m5F, A12, A13 and AhGh with increasing surface expression of the A2B5 ganglioside, a marker of differentiation. We asked whether the capacity of the sublines to differentiate was related to their stage of differentiation, as is characteristic of cells within the normal β-cell lineage. The answer this, we measured the effect of the differentiation inducer sodium butyrate (NaB, 1 mM) on proliferation, insulin content, secretion and biosynthesis, and the expression of A2B5 and 3G5 gangliosides by the sublines. Six days after exposure to NaB, cell numbers/dish ranged from (1-3) × 106 compared to (4-6) × 106 in control cultures. By day 2, AlGh, m5F, A12, A13 and AhGh cells exposed to NaB contained 1.5-, 1.4-, 1.4-, 1.2- and 1.0-fold higher amounts of insulin, respectively, and by day 6, 3.6-, 2.3- and 1.0-fold higher, and 1.2- and 2.4-fold lower, amounts of insulin, respectively, than control cells. After 2 days, insulin secretion from AlGh, m5F, A12, A13 and AhGh cells was 1.7-, 1.0-, 1.5-, 1.0- and 1.0-fold higher, respectively, and the rate of (pro)insulin biosynthesis 1.7-, 2.3-, 1.3-, 1.0- and 1.0-fold higher, respectively, than control cells. After 6 days, A2B5 ganglioside expression was increased 3-, 1.9- and 2-fold on m5F, A12 and A13 cells, respectively, but was not significantly altered on AlGh and AhGh cells. 3G5 ganglioside expression was increased 1.5- and 8.4-fold, respectively, on AlGh and m5F cells, but was unaltered on A12, A13 and AhGh cells. These results support the concept that the degree of RIN subline differentiation as induced by NaB reflects the pre-existing level of A2B5 ganglioside expression and therefore the stage of differentiation. © 1990.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 27 条
[1]   HYBRID INSULIN GENES REVEAL A DEVELOPMENTAL LINEAGE FOR PANCREATIC ENDOCRINE-CELLS AND IMPLY A RELATIONSHIP WITH NEURONS [J].
ALPERT, S ;
HANAHAN, D ;
TEITELMAN, G .
CELL, 1988, 53 (02) :295-308
[2]   A2B5-REACTIVE GANGLIOSIDE EXPRESSION IS AN INDEX OF DIFFERENTIATION IN RAT INSULINOMA (RIN) CELLS [J].
BARTHOLOMEUSZ, RK ;
CAMPBELL, IL ;
HARRISON, LC .
ENDOCRINOLOGY, 1990, 126 (04) :1927-1933
[3]   PANCREATIC-ISLET A2B5-REACTIVE AND 3G5-REACTIVE GANGLIOSIDES ARE MARKERS OF DIFFERENTIATION IN RAT INSULINOMA CELLS [J].
BARTHOLOMEUSZ, RK ;
CAMPBELL, IL ;
HARRISON, LC .
ENDOCRINOLOGY, 1989, 124 (06) :2680-2685
[4]  
EISENBARTH GS, 1982, P NATL ACAD SCI-BIOL, V79, P5066, DOI 10.1073/pnas.79.16.5066
[5]   CONTINUOUS, CLONAL, INSULIN-SECRETING AND SOMATOSTATIN-SECRETING CELL-LINES ESTABLISHED FROM A TRANSPLANTABLE RAT ISLET CELL TUMOR [J].
GAZDAR, AF ;
CHICK, WL ;
OIE, HK ;
SIMS, HL ;
KING, DL ;
WEIR, GC ;
LAURIS, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3519-3523
[6]   PRODUCTION OF HUMAN CHORIONIC-GONADOTROPIN IN HELA-CELL CULTURES [J].
GHOSH, NK ;
COX, RP .
NATURE, 1976, 259 (5542) :416-417
[7]   SODIUM-BUTYRATE STIMULATES SOMATOSTATIN PRODUCTION BY CULTURED-CELLS [J].
GREEN, R ;
SHIELDS, D .
ENDOCRINOLOGY, 1984, 114 (06) :1990-1994
[8]   THE POSSIBLE IMPORTANCE OF CONTACT BETWEEN PANCREATIC-ISLET CELLS FOR THE CONTROL OF INSULIN RELEASE [J].
HALBAN, PA ;
WOLLHEIM, CB ;
BLONDEL, B ;
MEDA, P ;
NIESOR, EN ;
MINTZ, DH .
ENDOCRINOLOGY, 1982, 111 (01) :86-94
[9]  
HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393
[10]   BUTYRIC-ACID, A POTENT INDUCER OF ERYTHROID DIFFERENTIATION IN CULTURED ERYTHROLEUKEMIC CELLS [J].
LEDER, A ;
LEDER, P .
CELL, 1975, 5 (03) :319-322